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ABSTRACT 
STRUCTURE-FUNCTION RELATIONSHIP BETWEEN QUERCETIN, ITS 
METHYLATED DERIVATIVES AND CYTOTOXICITY IN TRIPLE NEGATIVE 
BREAST CANCER CELLS 
 
by Jyoti Phatak 
 Quercetin is a member of the flavonoid family, found in fruits and vegetables, and has 
shown cytotoxic effects on many cancers, including breast cancer.  Quercetin’s 
methylated derivatives, 3-O-methyl quercetin, pentamethyl quercetin, isorhamnetin, and 
tamarixetin, differ in their substitution patterns of the methyl capping at the 5-hydroxyl 
groups.  Cell death assays performed on MDA-MB-231 cells showed increased 
cytotoxicity with quercetin and all its methylated derivatives, except pentamethyl 
quercetin, after 72 hours of treatment.  Loss of the mitochondrial outer membrane 
potential (MOMP) was seen using a JC-1 assay after 15 min incubation with compounds, 
except for pentamethyl quercetin.  We saw no change in MOMP after 24 hours of 
treatment with all quercetin derivatives.  Treatment with compounds showed no change 
in intracellular reactive oxygen species (ROS).  However, the generation of ROS by 
TBHP, positive control, was decreased after treatment, indicating that these compounds 
can function as an anti-oxidant by decreasing cellular ROS.  The quercetin derivatives 
showed cell cycle arrest at various phases.  Our data from the cell viability assay suggest 
that a structure-function relationship exists between methylation of the hydroxyl groups 
available on the quercetin molecule and its cytotoxicity in breast cancer cells, where the 
presence of at least one hydroxyl group is necessary for the compound to exert a 
cytotoxic effect.
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		 1 
Introduction 
 
 Cancer is the second leading cause of death in the United States and many other 
nations of the world (R. Siegel, Miller, & Jemal, 2015).  It is characterized by 
uncontrolled cell growth and invasion of bodily tissues such as the lung, colon, and 
breast.  The American Cancer Society estimates that in 2016, there will be 1,685,210 new 
cancer cases diagnosed and 595,690 cancer-related deaths in the United States alone 
 (R. L. Siegel, Miller, & Jemal, 2016).  
 Breast cancer is a diverse disease in reference to its origin, disease progression, 
and response to treatment (Ossovskaya et al., 2011).  With nearly 250,000 new cases in 
the U.S. each year, breast cancer accounts for 12% of all cancer diagnoses and is the 
leading cause of cancer-related death in women, claiming the lives of more than 40,000 
annually in the United States (R. L. Siegel et al., 2016).  Micro-array profiling of invasive 
breast carcinoma has identified five expression pattern subtypes, distinguished by the 
presence or absence of estrogen (ER), progesterone (PR) hormone receptors, and the 
human epidermal growth factor receptor (HER2).  These subtypes include luminal A 
(ER+ and/or PR+, HER2-), luminal B (ER+ and/or PR+, HER2+), normal breast-like, 
HER2 over-expressing (ER-, PR- and HER2 +), and basal-like or triple negative breast 
cancer (ER-, PR-, HER2-) (Bauer, Brown, Cress, Parise, & Caggiano, 2007).  Current 
treatment options for breast cancer largely depend on cancer stage and subtype and 
include local treatments such as surgery, radiation therapy, and systemic treatment such 
as chemotherapy.  For cancers overexpressing hormone receptors, the treatment plan may 
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also include hormone therapy, and HER2+ cancers may be additionally treated with 
targeted therapies (American Cancer Society, 2016).   
The triple negative breast cancer (TNBC) subtype accounts for approximately 
20% of all breast cancers (Hurvitz & Mead, 2015), and presents with an aggressive 
clinical course and a poor prognosis (Gluz et al., 2009).  Due to the absence of all three 
targetable surface receptors, TNBC presents a significant therapeutic challenge, as 
patients do not respond to the targeted receptor treatments available for other breast 
cancer subtypes (De Laurentiis et al., 2016).  Currently, the treatment choices for triple 
negative breast cancer are limited to chemotherapy, radiation, and combination therapies 
(Hurvitz & Mead, 2015).  In addition to causing unwanted side-effects such as nausea 
and the loss of hair follicles, these therapies are expensive and subject the patient to 
additional health risks such as drug toxicity and healthy cell damage (Botchkarev, 2003; 
Du, Osborne, & Goodwin, 2002; Early Breast Cancer Trialists’ Collaborative Group, 
2005).  Due to the challenges of treating TNBC and the harsh side effects of current 
treatment options, there is a pressing need to identify naturally available anti-cancer 
agents with therapeutic potential. 
 Flavonoids are naturally available bioactive compounds that belong to the family 
of phytochemicals, pigment molecules found in fruits, vegetables, soy products, tea, and 
red wine (Yan-Hwa, Chang, & Hsu, 2000).  These compounds have been associated with 
positive health outcomes and more recently have been investigated for their potential use 
as anti-cancer agents.  Flavonoids exhibit many functional characteristics lending to their 
promise in cancer therapeutics, including the ability to induce apoptosis, anti-angiogenic 
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activity, and inhibition of cell invasion, as well as antiproliferative properties and growth 
suppressive effects (N. Sharma, Dobhal, Joshi, & Chahar, 2011).  Based on their 
chemical structure, flavonoid compounds can be subdivided into different classes.  These 
classes include flavonols, flavones, isoflavones, flavanols, anthocyanidins, and 
flavanones (Table 1) (Heim, Tagliaferro, & Bobilya, 2002).   
Table 1  
Flavonoid sub-types and their examples. The table depicts different types of flavonoids 
and examples of the respective categories.  
 
Type of flavonoid Examples 
Flavonols Kaempferol, Quercetin, Myricetin 
Flavones Apigenin, Luteolin 
Isoflavones Daidzein, Genistein 
Flavanols Catechin, GalloCatechin 
Anthocyanidins Cyanidin, Delphinidin, Malvidin 
Flavanones Naringenin, Hesperetin 
 
Quercetin, a flavonol, is the most abundant of all the flavonoids (A. Sharma & 
Gupta, 2010).  Quercetin displays a spectrum of biological activities, functioning in anti-
viral, anti-bacterial, anti-carcinogenic, and anti-inflammatory capacities (A. Sharma & 
Gupta, 2010).  Studies have shown that upon ingestion, quercetin may undergo different 
metabolic conversions such as sulfation, methylation, and glucuronidation (Murota & 
Terao, 2003).  The methylated derivatives isorhamnetin, tamarixetin, 3-O-methyl 
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quercetin, and pentamethyl quercetin are naturally available and found in several fruits, 
vegetables, and herbs (Table 2). 
Table 2  
Natural sources of quercetin and its methylated derivatives. 
 
Name Natural source Reference 
Quercetin 
 
Berries, apples, 
onions, tea, nuts, 
and red wine 
(Crozier, Lean, 
McDonald, & Black, 
1997; Hertog, 
Hollman, & van de 
Putte, 1993; Wach, 
Pyrzyńska, & Biesaga, 
2007) 
Isorhamnetin 
 
Gingko Biloba, 
Onions, sea 
buckthorn 
(Park & Lee, 1996; Y. 
Wang, Cao, & Zeng, 
2005; Zu, Li, Fu, & 
Zhao, 2006) 
		 5 
Tamarixetin 
 
Indian head ginger, 
gingko biloba 
(Pandurangan, Bose, 
& Banerji, 2011; 
Peng, Li, Zhu, Han, & 
Yu, 2005) 
3-O-Methylquercetin 
 
Laurel leaf cistus, 
macela 
(Bettega, Teixeira, 
Bassani, Barardi, & 
Simões, 2004; Ustun, 
Ozcelik, Akyon, 
Abbasoglu, & 
Yesilada, 2006) 
Pentamethyl Quercetin 
 
Green tea, sea 
buckthorn, 
cranberries 
(“FIavonoI 
Glycosides,” 1967; 
Tsujimura & 
September, 1930) 
 
Previous studies have demonstrated the ability of quercetin and the methylated 
derivatives isorhamnetin, and tamarixetin to induce cell death in cancer cells (Z. Li & 
Gao, 2013; Nicolini et al., 2013; Sun et al., 2012).  Although the compounds are 
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suggested to cause cell death through the intrinsic pathway of apoptosis, the exact 
mechanism remains unclear.  
 Knowledge of quercetin’s bioavailability, including its intestinal absorption and 
metabolic conversion is crucial for understanding its anti-carcinogenic properties and for 
determining its therapeutic potential (Murakami, Ashida, & Terao, 2008).  Previous 
studies have demonstrated that unmodified quercetin exhibits a limited bioavailability.  
Hence, it has become necessary to identify a more bioavailable form of quercetin that can 
perform similar functions in vivo and can act as an effective anti-cancer agent.  
Additional studies have found that methylated flavonoids are more freely bioavailable 
and exhibit higher cytotoxic potential in comparison to their parent forms (Wen & Walle, 
2006). 
Our research compares the cytotoxicity between quercetin and its methylated 
derivatives isorhamnetin, tamarixetin, 3-O-methyl quercetin, and pentamethyl quercetin.  
We suggest that the methyl capping of the free hydroxyl groups on the parent quercetin 
molecule may make these derivatives of quercetin structurally more favorable as anti-
cancer agents.  Therefore, we conducted a study to determine the structure-function 
relationship between quercetin, its methylated derivatives, and cytotoxicity induced by 
these flavonols in triple negative breast cancer cells.  Understanding the structural 
characteristics of these flavonol compounds and the relationship between the structure 
and cytotoxic effects on cancer cells is critical for improving their efficiency as a 
chemopreventive or a chemotherapeutic drug candidate. 
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Literature Review 
Cell Death 
 Cell death is a critical biological process required for normal functioning of 
multicellular organisms.  The mechanism of death depends largely on morphological 
characteristics of a cell, the biochemical indicators present, and the circumstances that 
trigger cell death.  Based on these factors, cell death can be classified into the following 
categories: autophagy, apoptosis, necrosis, and necroptosis (Kroemer et al., 2009).  
Autophagic cell death.  Autophagic cell death or type II cell death is 
characterized by a unique cellular morphology, in which cell death takes place in the 
absence of chromatin condensation and instead is associated with large autophagic 
vacuolization of the cytoplasm (Kroemer et al., 2009).  It can be triggered by deprivation 
of growth factors, resulting in a decrease of intracellular nutrients and subsequent 
activation of the nutrient sensing signals that stimulate the autophagic pathway (Levine & 
Yuan, 2005). The pathway for autophagic cell death involves sequestration of 
cytoplasmic material in double-membrane vesicles known as autophagosomes (Fink, 
Cookson, Fink, & Cookson, 2005).  The degradation of the sequestrated cytoplasmic 
material within these vesicles releases nucleotides, amino acids, and free fatty acids, 
which are then reused for biosynthesis and production of ATP.  Autophagic cell death is 
further characterized by a lack of tissue inflammatory response (Levine & Yuan, 2005).   
Autophagy has also been shown to play a role in controlling unregulated cell 
growth associated with tumor development.  An example of this is the study of a tumor 
suppressor gene, beclin 1, a human homolog of the yeast autophagy gene APG6 (Liang et 
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al., 1999).  Beclin 1 interacts with the anti-apoptotic protein Bcl-1, which further prevents 
the Bax-dependent release of mitochondrial cytochrome c (Koneri, Goi, Hirono, 
Katayama, & Yamaguchi, 2007).  The role of autophagy in cancer can be cancer 
preventing or cancer promoting.  It provides cancer prevention by sequestering damaged 
organelles, permitting cellular differentiation, increasing protein catabolism, and 
stimulating autophagic cell death.  Autophagy promotes cancer by helping with the 
survival of starving cells, which may facilitate tumor initiation and progression (Levine 
& Yuan, 2005).  When a tumor grows beyond its supply of blood, it undergoes nutrient 
starvation.  Previous studies suggest that these transformed cells may utilize autophagy 
for cell survival under nutrient deprivation conditions (Lum, DeBerardinis, & Thompson, 
2005).  
Apoptosis.  Apoptosis is morphologically characterized by rapid chromatin 
condensation and budding of the cellular membrane, along with the formation of 
apoptotic bodies containing well-preserved organelles, which are later phagocytosed and 
digested by nearby resident cells (Kroemer et al., 2009).  In preparation for cell death, 
apoptotic cells undergo double-stranded cleavage of nuclear DNA at the linker region 
between nucleosomes, resulting in oligonucleosomal DNA fragments (Kerr, Winterford, 
& Harmon, 1994).  Several distinct subtypes of apoptosis exist, which are 
morphologically similar.  Various stimuli such as irradiation, growth factor deprivation, 
and chemotherapeutic drugs trigger these subtypes of apoptosis, all of which ultimately 
lead to DNA damage.  There are two main pathways through which apoptosis may be 
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initiated in a cell: the extrinsic pathway (receptor-mediated) and the intrinsic pathway 
(mitochondrial-mediated) (Kroemer et al., 2009). 
Extrinsic pathway.  The extrinsic pathway of apoptosis, also known as the 
cytoplasmic pathway, is activated through Fas death receptor, a member of the tumor 
necrosis factor (TNF) receptor family (S. Wang & El-Deiry, 2003).  This pathway is 
initiated by ligation of cell surface death receptors (DRs) such as Fas, CD95, and TNF-
related apoptosis-inducing ligand (TRAIL) with their extracellular ligand.  The ligation of 
CD95 or the TRAIL agonistic receptors R1 and R2 by their ligands results in the 
clustering of receptor death domains, which then recruits adaptor molecules such as Fas-
associated death domain (FADD) or TNF receptor-associated death domain (TRADD) 
(Kischkel et al., 2000).  The complex formed by the ligand-receptor and adaptor protein 
is referred to as the death-inducing signaling complex (DISC).  Formation of this 
complex leads to the assembly of initiator caspase-8 and caspase-10, which self-processes 
to activate effector caspases -3, 6, and 7 through release of activated caspase enzymes 
(O’Brien & Kirby, 2008).  The release of activated caspase enzymes results in DNA 
cleavage and fragmentation, which are characteristic of apoptosis (Martin, 2014).  
Intrinsic pathway.  The intrinsic, or mitochondrial pathway of apoptosis is 
initiated within a cell in response to triggers such as cellular stress, DNA damage, radical 
oxygen species (ROS), radiation, hormone or growth factor deprivation, 
chemotherapeutic agents, and cytokines, or glucocorticoids (Grunnet et al., 2009; 
Pelicano et al., 2003; Schmidt et al., 2004).  The mitochondria integrate the pro-apoptotic 
signaling environment via the B-cell lymphoma 2 (Bcl-2) family of proteins to control 
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cell death (Elkholi, Renault, Serasinghe, & Chipuk, 2014).  The Bcl -2 family proteins 
are critical regulators that reside immediately upstream of the mitochondria and consist of 
both anti- and pro-apoptotic members.  These proteins have conserved a-helices with 
sequence conservation clustered in the Bcl-2 homology (BH) domain (Kutzki et al., 
2002).  The anti-apoptotic members exhibit homology in all BH1 to BH4 segments.  The 
pro-apoptotic members are further subdivided into multidomain members Bax and Bak 
and the BH3-only members including Bid, Bim, Bad, and Puma (Scorrano & Korsmeyer, 
2003).  
For pro-apoptotic activity, the Bcl-2 family members must undergo 
heterodimerization of the BH3 domain (Adams & Cory, 1998).  During apoptosis, Bax, a 
21 KDa protein, translocates to the mitochondria, in which it undergoes a conformational 
change before integrating itself into the mitochondrial membrane (Walensky & 
Gavathiotis, 2011).  The translocation of Bax can be triggered by different stimuli such as 
alterations in mitochondrial bioenergetics or Cathepsin D (lysosomal aspartyl protease) 
(Bidère et al., 2003; Smaili, Hsu, Sanders, Russell, & Youle, 2001).  Upon localization to 
the mitochondria, Bax undergoes a conformational change from its monomer form to a 
pore-forming oligomer, generating a proteolipid pore in the outer mitochondrial 
membrane (Epand, Martinou, Montessuit, Epand, & Yip, 2002).  Formation of this pore 
causes permeability of the membrane and leads to the release of mitochondrial proteins 
such as cytochrome c and mitochondria-derived activator of caspase (i.e., IAP-binding 
protein).  Cytochrome c, once released into the cytosol, interacts with cellular adaptor 
proteins (i.e., Apaf-1) and procaspase-9.  The binding of these three components forms 
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the apoptosome, which then activates procaspase-3.  The activated caspase-3 further 
initiates the caspase cascade that leads to apoptosis (Figure 1) (Scorrano & Korsmeyer, 
2003).                          
       
Figure 1. Schematic representation of intrinsic pathway of apoptosis. Intrinsic apoptosis 
is triggered by apoptotic signals which activate the BH3 only proteins, causing the release 
of apoptotic molecules Bax and Bak from the outer mitochondrial membrane and the 
subsequent loss of mitochondrial outer membrane potential by the formation of the 
permeability transition pore. Cytochrome c is released into the cytosol, complexing with 
the APAF-1 and caspase-9 to form the apoptosome. This complex activates  
caspase-3, triggering the caspase cascade leading to apoptosis. 
 
 Caspases play a crucial role in apoptosis.  They exist as inactive pro-enzymes which 
are then activated by cleavage at specific aspartate sites (Martin, 2014).  The caspase 
family consists of 15 mammalian members, divided into three subclasses based on the 
structure and function of their prodomains (Chowdhury, Tharakan, & Bhat, 2008).  
Caspases with larger prodomains (caspase-1, 4, 5, 12, 13, and 14) play a role in cytokine 
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maturation and inflammatory responses and are grouped as inflammatory caspases.  The 
second subclass includes caspases-8 and 10, which possess long prodomains (>90 amino 
acids) and constitute the initiators of apoptosis caspases.  The last group of caspases, 
those with shorter prodomains (caspase-3, 6, and 7), are called effector or executioner 
caspases (Chowdhury et al., 2008).  Procaspases are distinct caspases that are present in 
the cytoplasm in an inactive form. They can be activated by (1) exposure to another 
activated caspase, (2) autocatalysis, or (3) binding with an activator protein such as Apaf-
1, procaspase-9 and cytochrome c (O’Brien & Kirby, 2008).  
BH3-only members (Bim, Puma, Bid, Bcl-xL/Bcl-2-associated death promoter 
(Bad), Bcl-2-interacting killer (Bik), and Noxa) display sequence conservation only in the 
amphipathic a-helical BH3 region and control anti-apoptotic Bcl-2 proteins (Adams & 
Cory, 1998).  These proteins stimulate the apoptotic pathway by binding to a groove on 
the surface of pro-survival proteins via their BH3 region.  Different apoptotic stimuli 
require different BH3-only proteins for killing cells.  For example, Puma is shown to be 
necessary for p53-mediated apoptosis, which is induced by DNA damage or anoxia 
(Michalak, Villunger, Adams, & Strasser, 2008).  The BH3-only protein Bim is critical 
for inducing cell death in response to growth factor deprivation, ER stress, and 
deregulated calcium flux in diverse cell types (Puthalakath et al., 2007).  The Bax and 
Bak proteins also interact with BH3-only proteins.  Upon activation by caspase-8 
cleavage, cytosolic p22 Bid engages with Fas or TNFR1 receptors on the cell surface, 
resulting in the formation of truncated Bid (tBid).  The tBid further interacts with Bax to 
induce conformational change and oligomerization of Bax (Wei et al., 2000).  
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Studies have shown initiation of apoptosis through direct binding of Bim and tBid to Bax 
or Bak (Kuwana et al., 2005).  Furthermore, it was recently demonstrated that genetic 
deletions of Bid, Bim, and Puma prevented the homo-oligomerization of Bax and Bak, 
and thereby the cytochrome c mediated activation of caspases in response to death signals 
in neurons and T-lymphocytes, even in the presence of other BH3 molecules 
 (D. Ren et al., 2010).  
 In addition to the release of cytochrome c, the oligomerization of Bax causes the 
release of several other pro-death substances from the mitochondria such as apoptosis 
inducing factor, Smac/DIABLO, HtrA2/Omi, and several procaspases.  Smac and its 
murine homolog, DIABLO, are nuclear- encoded mitochondrial proteins that contain a 
localization signal from the mitochondria.  This signal is proteolytically removed upon 
mitochondrial import, generating a mature 23kDa protein. This mature protein exposes 
the IAP-binding motif (IBM) at the N-terminus of Smac/DIABLO (Fulda & Debatin, 
2006).  Although the mitochondrial function of Smac/Diablo is not well-understood,  
in vitro studies conducted in Smac -/- cells have demonstrated that in the absence of 
Smac, cleavage of procaspase-3 is inhibited despite the addition of cytochrome c (Fulda 
& Debatin, 2006).   
Smac/DIABLO also promotes caspase activation through neutralization of 
inhibitor of apoptosis proteins (IAPs).  Omi/HtrA2 is a nuclear-encoded, 49 kDa protein 
with an N-terminal mitochondrial localization signal that mediates its translocation into 
the mitochondrial intermembrane space (Saelens et al., 2004).  Similar to 
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Smac/DIABLO, Omi/HtrA2 blocks the IAPs through its N-terminal IAP-binding motif, 
presented in a trimeric configuration (Yang, Church-Hajduk, Ren, Newton, & Du, 2003).  
Emerging evidence suggests an additional apoptotic pathway which proceeds in 
the absence of caspases, a mechanism known as caspase-independent cell death  
(Lockshin & Zakeri, 2004).  The caspase-independent pathway of cell death has been 
associated with several factors, including apoptosis-inducing factor (AIF) and 
endonuclease G.  The mitochondrial-nuclear translocation of AIF is one example of 
caspase-independent apoptosis.  Apoptosis-inducing factor (AIF) resides primarily in the 
mitochondrial intermembrane space in healthy cells and is thought to promote cell death 
by binding to DNA and inducing large-scale fragmentation (Norberg, Orrenius, & 
Zhivotovsky, 2010).  The release of AIF is mediated by direct proteolysis of the protein, 
calpain.  Calpains are a family of calcium-dependent, non-lysosomal cysteine proteases, 
which upon activation are shown to cause cleavage of AIF.  Studies have shown that the 
deletion of calpain-1 alone is sufficient to affect AIF truncation (Polster, Basanez, 
Etxebarria, Hardwick, & Nicholls, 2005).  Redistribution of AIF to the nucleus and  
large-scale DNA fragmentation are both caspase- and ATP-independent processes 
(Daugas et al., 2000).  Endonuclease G (Endo G) may function similarly to AIF in 
promoting caspase-independent cell death.  While it was initially identified as a protein 
involved in mitochondrial DNA replication, recent studies have shown Endo G to be 
released from the mitochondria during apoptosis, with subsequent nuclear localization 
and apparent involvement in nuclear DNA breakdown (L. Y. Li, Luo, & Wang, 2001; 
van Loo et al., 2001).  
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Necrosis.  Necrotic cell death is characterized by an irreversible loss of plasma 
membrane integrity, gain in cytosolic volume, and marked swelling of organelles 
(Golstein & Kroemer, 2007).  It is a consequence of crosstalk between several 
biochemical and molecular pathways at different cellular levels (Festjens, Vanden 
Berghe, & Vandenabeele, 2006).  Several molecular signals have been identified as 
necessary for necrotic cell death such as members of TNF family, RIP1, PARP, and 
Cyclophilin D (CypD) (Golstein & Kroemer, 2007).  
Members of the TNF receptor family are shown to initiate necrotic cell death.  
When treated with TNF-a, L929 mouse fibrosarcoma cells initiate a complex multi-step 
signal transduction pathway in which FAS-associated death domain (FADD) is recruited 
to the TNF receptor-1, and necrosis is induced presumably through the death domain 
(Boone et al., 2000). Necrosis in L929 cells is dependent on the death domain of TNFR-
55 (Boone et al., 2000).  When L929 cells were transfected with the FAS gene, apoptotic 
cell death was seen after anti-FAS addition, yet the cell line maintained sensitivity to the 
necrotic effect of TNF, indicating that apoptotic and necrotic events can coexist in the 
same cell (Vercammen et al., 1998).  
Receptor inducing protein 1 (RIP1) is a specific kinase which is recruited to the 
death-inducing signaling complex after the occupation of TNF-R1, and when activated it 
can moderate several effects including necrosis (Golstein & Kroemer, 2007).  Jurkat cells 
deficient in RIP1 resist necrotic cell death induced by the Fas/TNF-R/TRAIL-R pathway, 
implicating that RIP1 plays a critical role as a molecular signal for necrosis.  There is also 
evidence of RIP1 involvement in other models of necrotic signaling (Chan et al., 2003).  
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Knockdown of RIP1 expression has been shown to interrupt the lethal signal transduction 
cascade in necrosis induced by alkylation of DNA and activation of (PARP) poly(ADP-
ribose) polymerase (Xu, Huang, Liu, & Han, 2006).  
 PARP (ADP-ribose) polymerase, is a nuclear enzyme containing a Zn-binding 
domain.  Activation of PARP can result in necrotic cell death through depletion of NAD+ 
(Galluzzi et al., 2011), and subsequent necrosis is initiated by over-activation of the 
DNA-repair enzyme PARP-1.  PARP inhibitors block necrotic cell death in Burkitt’s 
lymphoma (Ha & Snyder, 2016).  
Cyclophilin D (CypD) is a mitochondrial matrix protein that can interact with 
inner membrane proteins.  Knockdown of the gene encoding CypD induces resistance to 
necrosis caused by ROS or Ca2+ overload in hepatocytes and fibroblasts (Nakagawa et 
al., 2005).  CypD is also a mitochondrial target of cyclosporin A, which has been 
previously shown to decrease cell loss caused by necrotic cell death, for example, TNF-a 
treated hepatocytes (Pastorino et al., 1996).  CypD interacts with the inner membrane 
proteins including adenine nucleotide translocator (ANT), which participates in the 
opening of non-specific channels causing dissipation of the inner mitochondrial 
transmembrane potential (Nakagawa et al., 2005).  
Necroptosis.  In contrast to the unregulated and uncontrollable cell death process 
associated with cellular necrosis, a programmed form of necrotic death may also occur 
through a process known as ‘necroptosis’.  The necroptotic mechanism of cell death is 
observed in specific cellular conditions such as those arising from neurodegeneration,  
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ischemia-perfusion injuries, and infection.  It is known to be initiated by activation of 
several receptors such as CD95 (FAS) binding to CD95L (FASL), TNF receptor 1 
(TNFR1), TNFR2, TNF-related apoptosis-inducing ligand receptor 1 (TRAIL1), and 
TRAIL2.  The TNF receptors stimulate TRADD to recruit RIP1K.  The RIP1K and 
RIP3K receptor-interacting proteins, in the absence of caspase-8, subsequently 
phosphorylate, leading to the formation of the necrosome.  The formation of the 
necrosome by these receptor-interacting proteins such as RIP1 and RIP3 is considered 
one of the most critical characteristics of necroptosis. (Wu et al., 2014). 
Flavonoids 
 Flavonoids are potent natural compounds which have long been associated with 
positive health outcomes.  A member of the polyphenol family, flavonoids are widely 
distributed in a variety of plants, vegetables, and fruits, with more than 4000 naturally 
occurring forms already identified (Galati & O’Brien, 2004).  Because of their many 
health-promoting attributes, flavonoids have been a research target for some years.  More 
recent insight regarding the biochemical mechanisms producing flavonoid-associated 
health benefits have led investigators to explore a potential therapeutic application for 
these compounds.  Perhaps most notably, some flavonoids have been shown to impede 
the initiation, promotion, and progression of cancer by regulating enzymes and signaling 
pathways that participate in vital cell processes such as cell differentiation, apoptosis, 
angiogenesis, metastasis, and inflammation (W. Ren, Qiao, Wang, Zhu, & Zhang, 2003).  
Structure of flavonoids.  Flavonoids have a generic structure similar to the 
diphenyl propanes, C6-C3-C6, with two benzene rings joined by a three-carbon chain 
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with an oxygen bridge, resulting in the formation of two phenolic rings (A and B) and a 
pyrane ring (C).  Based on variations in the number and the positioning of the hydroxyl 
groups, flavonoids are further classified into six major groups:  flavonols, flavones, 
flavanones, anthocyanidins, isoflavones, and flavanols.  Some flavonoids have hydroxyl 
groups on their structure at positions 3, 5, 7, 3’,4’, and/or 5’, with the exception of the 
isoflavone group, where the B-ring is attached to 3-carbon on pyran.  
Flavonoids also vary in their hydroxyl group attachments.  When present without 
sugar molecules attached, they are referred to as aglycones, whereas when one or more 
sugar molecules have replaced the hydroxyl groups, they are called flavonoid glycosides.  
The presence of glycosides on flavonoid molecules plays a crucial role in the 
bioavailability of these molecules within the human body.  The hydroxyl groups on 
flavonoids may also be replaced with methyl groups (methyl capping), resulting in 
 O-methylated flavonoids.  The presence of the methyl capping is necessary for flavonoid 
cell permeability and anti-cancer properties (Walle, 2009).  
Flavonoid as anti-oxidants.  Flavonoids are most commonly recognized for their 
anti-oxidant activity (Pietta, 2000).  The mechanism of anti-oxidant action in the body 
may proceed through several channels such as by inhibition of enzymes responsible for 
reactive oxygen species-formation, by chelation of trace elements responsible for free 
radical production, by direct scavenging of reactive oxygen species, and by up-regulation 
or protection of antioxidant defenses (Pietta, 2000).  In flavonoids, the anti-oxidant 
activity can be directly attributed to the availability of phenolic free hydroxyl groups.  
These phenolic hydroxyl groups provide the flavonoid molecules with their electron-
		 19 
donating ability to detoxify free-radicals (Murakami et al., 2008).  Although studies have 
suggested that flavonoids possess both excellent iron chelating and radical scavenging 
properties, there are inconsistencies regarding the structure-function relationship and 
influence of structure on anti-oxidant potential.  The B-ring hydroxyl configuration is 
thought to be the most important determinant of the compound’s ability to scavenge 
reactive oxygen species (ROS) and reactive nitrogen species (RNS) (Haenen, Paquay, 
Korthouwer, & Bast, 1997).  The hydroxyl groups on the B-ring donate hydrogen and an 
electron to hydroxyl, peroxyl, and peroxynitrite radicals, while A-ring substitution of the 
hydroxyl group has no known significance in relation to the anti-oxidant activity (van 
Acker et al., 1996).  Planarity allows conjugation, electron dislocation, and increase in 
flavonoid radical stability.  The absence of the 3-OH revokes the coplanarity and 
conjugation, thereby undermining the anti-oxidant potential of flavonoids (van Acker et 
al., 1996). 
Role of flavonoids. Flavonoids have demonstrated several biological properties 
that may play a significant role in cancer chemoprevention.  In addition to serving as anti-
oxidants, flavonoids may interfere with cancer-associated cellular functions by inhibiting 
cell division and proliferation, reducing oxidative stress levels, and inducing apoptosis, as 
well as by aiding in cellular detoxification and helping to stimulate the immune system 
(W. Ren et al., 2003).  A large body of data has been generated to study the relationship 
between the consumption of flavonoid-rich foods and cancer prevention (N. Sharma et 
al., 2011). 
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Quercetin 
The flavonol quercetin is the most abundant of all flavonoids (A. Sharma & 
Gupta, 2010).  The chemical formula for quercetin is C15H10O7 with a molecular weight 
of 302.24 g/mole.  Quercetin is found in various food products such as berries, apples, 
onions, tea, nuts, and red wine (Crozier et al., 1997; Hertog et al., 1993; Wach et al., 
2007).  The five hydroxyl groups on the structure of quercetin make it the most potent 
anti-oxidant among all known flavonoids (Letan, 1966).  Average dietary intake of 
quercetin has been estimated as 5-40 mg/day, although these levels may vary with the 
consumption of a flavonol-rich diet.  Still, dietary consumption remains far below the 
suggested upper limit, as quercetin is recognized as safe in oral dosages of 1,000 mg/day 
or intravenous dosages of 765 mg/day (Harwood et al., 2007). 
 When ingested, the quercetin glycoside is cleaved by b-glycosidase, resulting in 
the formation of quercetin aglycone (Spencer, Kuhnle, Williams, & Rice-Evans, 2003).  
The bioavailability of quercetin aglycone and its glycosides plays a significant role in the 
efficacy of their biochemical properties.  Quercetin is commonly digested in its glycoside 
form, where one or more sugar groups are bound to the phenolic group by glycosidic 
linkage (Murota & Terao, 2003).  Quercetin glycosides from the diet pass through small 
intestine, and enter the cecum and colon, in which they are hydrolyzed to aglycone 
(where the sugar moiety is removed from the glycosidic form of quercetin) by 
enterobacteria (Noteborn, Jansen, Benito, & Mengelers, 1997).  The aglycone form of 
quercetin is lipophilic, and thus passes through the phospholipid bilayer of cellular 
membranes to enter the circulation, in which it is subjected to O-methylation, 
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glucuronidation, and/or sulfation in the liver (Noteborn et al., 1997). A human study 
conducted to evaluate the absorption of quercetin supplementation showed that oral 
quercetin effectively increased blood plasma levels after a 2-week regimen.  In the study, 
18 men and 18 women were given daily oral quercetin aglycone supplementation for two 
weeks, at a dose of (Q50) 50 mg/day, (Q100) 100mg/day, and (Q150) 150mg/day.  
Though researchers observed varying levels of individual blood plasma concentrations 
based on the participant’s fat mass or gender, study participants, on average, were able to 
absorb ~150 mg/day (Egert et al., 2008). Compared with the baseline, there was a 
significant increase in the plasma concentrations of quercetin by 178% (Q50), 359% 
(Q100), and 570% (Q150) (Egert et al., 2008).  
Quercetin as an anti-oxidant. Quercetin possesses a range of favorable 
biochemical attributes, including anti-inflammatory, anti-histaminic, anti-oxidant, anti-
carcinogenic, and anti-viral properties. (Russo, Spagnuolo, Tedesco, Bilotto, & Russo, 
2012).  Quercetin is considered a strong anti-oxidant due to its ability to scavenge free 
radicals and bind transition metal ions.  These properties allow quercetin to inhibit lipid 
peroxidation, which is a process that involves the conversion of unsaturated fatty acids to 
free radicals (Hollman, van Trijp, Mengelers, de Vries, & Katan, 1997).  The radical-
scavenging activity of quercetin is largely dependent on the O-dihydroxyl structure 
(catechol) at the 3’ and 4’ –positions on the B ring of the quercetin molecule (Letan, 
1966).  The electron donating ability of quercetin to ROS prevents damage to cellular 
DNA.  Additionally, at high intracellular concentrations, quercetin acts as a pro-oxidant.  
Quercetin at concentrations greater than 40 µM has shown to induce apoptosis in 
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transformed cells, presumably by becoming an ROS itself (Metodiewa, Jaiswal, Cenas, 
Dickancaite, & Segura-Aguilar, 1999).  
Quercetin’s effects on cancer.  Apoptosis induced by quercetin occurs through 
the mitochondrial-mediated pathway (Chien et al., 2009; Duo, Ying, Wang, & Zhang, 
2012; Kim, Moon, Ahn, & Cho, 2013).  The mitochondrial pathway of apoptosis has 
been confirmed by a measured loss of mitochondrial outer membrane potential (MOMP) 
upon treatment with quercetin in various cancer cell lines.  Exposure to quercetin causes 
loss of MOMP in colorectal cancer (HT-29) cells, data were supported by a decrease in 
the cell viability, an increase in apoptosis rate, and activation of caspase-3, in correlation 
with activation of caspase-9 (Z. Li & Gao, 2013).  In a study of triple negative breast 
cancer cells treated with quercetin at a concentration range of 200-250 µM, results have 
shown an increase in the production of p53, increased activation of caspases-9 and 3, and 
increased levels of cytochrome c (Chien et al., 2009), consistent with activation of 
mitochondrial apoptosis.  
Quercetin also induces cell cycle arrest at G1 and/or G2/M phase in several 
cancer cell lines such as colon, leukemia, breast, lung, hepatoma, and oral cancer.  An 
investigation of the molecular signaling pathway of quercetin showed the induction of 
apoptosis in human breast MCF-7 cancer cells and cell cycle arrest at S phase.  These 
changes were accompanied by alterations in the levels of cell cycle regulated proteins 
such as CDK2, and cyclins A and E, suggesting that alterations in cell division may play 
an important role in apoptosis induced by quercetin. (Chou et al., 2010).   
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 Quercetin is also able to cause mitochondrial-mediated cell death in the absence 
of p53 (Zhang, Zhao, & Wang, 2009).  Additionally, quercetin may work with death-
domain stimulators such as tumor necrosis factor a (TNF-a)- related apoptosis-inducing 
ligand (TRAIL) to induce cell death in cancer cells through the extrinsic apoptosis 
pathway (Siegelin, Reuss, Habel, Rami, & von Deimling, 2009).  
Methylated derivatives of quercetin.  Methylated derivatives of quercetin act as 
potent chemopreventive agents with increased hepatic metabolic stability (Walle et al., 
2007).  Blocking of the free hydroxyl groups by methylation eliminates the influence of 
highly efficient conjugation pathways, thereby limiting the metabolic clearance from the 
intestinal epithelial cells as well as in the liver (Wen & Walle, 2006). 
Isorhamnetin, a 3¢-O-methylated metabolite of quercetin, is a flavonol, commonly 
found in plants such as Ginkgo biloba Linne and Persicaria thunbergii H.Gross (Lee et 
al., 2008).  Isorhamnetin exhibits anti-tumor and anti-oxidant activity in several cell lines, 
including human hepatocellular and human esophageal squamous cancer cells.  The 
biological effects of quercetin may be largely attributed to the activity of its derivatives 
such as the 3-O methylated metabolite isorhamnetin.  Isorhamnetin can induce both  
dose- and time-dependent apoptosis and necrosis in HCT-116 colorectal cancer cells, 
which are also shown to arrest at G2/M phase of the cell cycle upon treatment (Jaramillo 
et al., 2010).  In Lewis lung cancer cells (LLC), isorhamnetin-induced apoptosis occurs 
through activation of the mitochondrial pathway, demonstrated by loss of MOMP, 
increased mitochondrial Bax, release of cytochrome c into the cytosolic fraction, 
decreased production procaspase-9, and increased caspase-3 levels, along with increases 
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in PARP cleavage, DNA fragmentation, and sub-G1 apoptotic bodies.  In C57BL/6 mice 
bearing LLC, treatment with isorhamnetin at dosage levels of up to 0.5 mg/Kg resulted in 
a significant reduction in the size and weight of excised tumors (Lee et al., 2008).  
Isorhamnetin has also been shown to have potential inhibitory effects on adhesion, 
migration, and invasion of MDA-MB 231 human breast carcinoma cells.  These 
inhibitory effects of isorhamnetin are achieved by downregulating the activity of (Matrix 
Metalloproteinase) MMP-2 and MMP-9, a family of endopeptidases that have the ability 
to degrade all ECM components and therefore play a significant role in tumor invasion 
and tissue remodeling (C. Li et al., 2015). 
Less-studied methylated derivatives of quercetin may also have therapeutic 
potential in cancer treatment. Flavonoid aglycone, 3-O-methylquercetin, is naturally 
found in Nicotiana tabacum L. trichomes.  It has been shown to participate in the 
inhibition of prostaglandin and phosphodiesterase, the inactivation of free radicals and in 
inhibition of viral RNA synthesis (Schwingel, Schwingel, Storch, Barreto, & Bassani, 
2014).  The metabolite 3-O methyl quercetin has also been studied for its anti-viral 
activity, where it inhibits viral replication at an early stage, reducing the viral RNA and 
protein synthesis (Schwingel et al., 2014).  Though its anti-cancer activity has not yet 
been extensively studied, the potential for 3-O methyl quercetin in cancer treatment is 
notable due to its cytotoxic activity in various human cancer cell lines such as MCF-7 
breast cancer cells, Hep2 hepatoma cells, HL60-leukamia cells, A431-epidermoid 
carcinoma, HeLa-cervical cancer cells, and HOS-hosteosarcoma (Carini, Klamt, & Linck, 
2014).  Similarly, pentamethyl quercetin induces weak cytotoxicity in MDA-MB 231 
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cells, along with cell cycle arrest at G1 phase (Yadegarynia et al., 2012).  This compound 
has also been found to have low toxicity with the ability to reverse drug resistance for 
SN-38 (an active metabolite of irinotecan, a drug used for cancer treatment and a 
substrate of ABCG2) in breast cancer resistance protein ABCG2 overexpressing cells 
(Gallus, Juvale, & Wiese, 2014). 
 Tamarixetin, a naturally occurring flavonoid, is structurally very similar to 
quercetin, and very little research has been conducted to explore its potential application 
in anti-tumor therapy.  Tamarixetin contains a methoxyl group at position 4¢ of the 
phenylbenzo-g-pyrone core (Spencer et al., 2003).  It has been reported to be more 
cytotoxic and a more potent inducer of apoptosis than quercetin in human myeloid HL-60 
cells (Nicolini et al., 2013).  The methylated derivative of tamarixetin is also capable of 
passing through biological membranes more easily than quercetin due to its high 
lipophilic nature and its ability to reach a higher intracellular concentration (Nicolini et 
al., 2013).  This review exemplifies the need for continued research investigating the 
anticancer potential of methylated flavonoid compounds.  Our objective was to compare 
the quercetin compound to its methylated derivatives, in their ability to induce cell death 
in triple negative breast cancer cells.  
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Methods 
Materials 
Flavonoids were purchased from Indofine Chemicals and prepared by dissolving 
in 100% dimethyl sulfoxide (DMSO) to produce a 50 mM stock solution.  
Cell Culture 
MDA-MB 231 cells (human breast adenocarcinoma cells), HeLa cells (cervical 
cancer cells), and MCF-10A cells (immortalized non-transformed primary breast 
epithelial cells) were purchased from the American Type Culture Collection (ATCC).  
MDA-MB 231 and HeLa cells were maintained using Dulbecco’s Modification of 
Eagle’s medium (DMEM) with high glucose, L-glutamine, and sodium pyruvate 
(Corning), and supplemented with 10% fetal bovine serum (FBS) and 1% antibiotic as 
recommended by ATCC.  The MCF-10A cells were grown in mammary epithelial cell 
growth media (MEGM) (Lonza) with 25.0 mL horse serum (Invitrogen), 0.5 ml human 
epithelial growth factor (hEGF), 0.5 mL hydrocortisone, 2.0 mL bovine pituitary extract 
(BPE), 0.5 mL of gentamycin sulfate (GA-1000), and 0.5 mL insulin (Lonza).  All cell 
lines were grown at 37ºC under humidified 5% CO2. 
Cell Viability Assay 
Cell viability was measured using a trypan blue exclusion assay (TBE). For this 
assay, 0.5 x 106 cells per well were seeded in a 6-well culture dish.  After 24 h of 
incubation, the medium was pipetted out and the cells were treated with 12.5, 25, 50 and 
100 µM of flavonoids or with the vehicle control, dimethyl sulfoxide (DMSO).  Cells 
were harvested by trypsinization at 72 h post treatment and re-suspended in 1 mL of 1X 
PBS.  The cell suspension was mixed with trypan blue at a 1:1 ratio.  Cells lacking trypan 
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blue were counted using a TC10 automated cell counter (Bio-Rad) and the percentage of 
live cells was calculated in comparison to the DMSO control.  
Measuring Mitochondrial Outer Membrane Potential 
Loss of mitochondrial outer membrane potential (MOMP) was determined using 
flow cytometry.  When the mitochondrial membrane is intact, JC-1 dye (Invitrogen) 
forms red aggregates, but a loss of membrane permeability leads to a decrease in the 
proton gradient across the membrane, which resulted in the release of green JC-1 
monomers into the cytosol.  The ratio of red/green fluorescence is an indicator of MOMP 
change, with a higher ratio indicating intact mitochondrial membranes and a lower ratio 
indicating loss of MOMP (Facts, 2011).  The protocol was followed per manufacturer 
recommendation (Invitrogen).  Briefly, 1 x 106 MDA-MB 231 cells were treated for 15 
min with 100 µM of the flavonoid compounds or CCCP as a positive control and DMSO 
as a negative control treatment, along with 15 µL of the 200 µM JC-1 dye in 1X PBS at 
37ºC.  Change in the MOMP was then measured on a FACSCalibur cell analyzer (BD 
Biosciences) by collecting and analyzing 25,000 events using a CellQuest Pro flow 
cytometry analysis software.  The parameters for the flow cytometer were set to FSC: E-
1, SSC: 326, FL1: 320, FL2: 300, and compensation of FL2: 22% FL1.  The assay was 
repeated with 0.3 x 106 cells per well seeded in a 6-well dish.  After 24 h, the media was 
replaced with the treatment and incubated for another 24 h. A washout experiment was 
also performed as described above, with the exception that cells were washed with 1X 
PBS three times following the harvesting of cells and before the cells were being 
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analyzed.  The samples were analyzed on the flow cytometer using Cell Quest Pro, as 
they were for the 15 min treatment.  
Detection of Reactive Oxygen Species 
The generation of reactive oxygen species upon treatment with flavonoids was 
measured using CM-H2DCFDA dye.  The dye (5-(and-6)-chloromehtyl-2’, 7’-
dichlorodihydrofluorescin diacetate) is an acetyl ester that passively diffuses into the 
cells, in which its acetate groups are cleaved by intracellular esterases and its thiol-
reactive chloromethyl group reacts with intracellular glutathione and other thiols.  
Subsequent oxidation leads to the formation of a fluorescent adduct that is trapped inside 
the cell (Eruslanov & Kusmartsev, 2010).  The CM-H2DCFDA dye was dissolved in 
DMSO to prepare a 10 mM stock.  For this experiment, 1.5 x 105 cells per well were 
seeded in a 6-well dish. After 24 h, the cells were harvested and resuspended in 1 mL 1X 
PBS.  The cells were treated and stained together for 15 min using 10 µM CM-
H2DCFDA dye at 370C.  Cells were also treated with DMSO as a negative control and 5 
µM tert-Butyl-hydroperoxide (TBHP) as a positive control and further analyzed using a 
FACSCalibur cell analyzer (BD Bioscience).  The flow cytometer instrument settings 
were set to FSC: E-1, SSC: 358, FL1: 245, and FL2: 300 and were kept constant for all 
samples. 
Cell Cycle Analysis  
 Cells were seeded at 2.5 x 105 cells in a 10 mm culture dish (Corning). After 24 h, 
cells were treated with flavonoid compounds. Then 24 h and 48 h after treatment, cells 
were harvested via trypsinization and counted on an automated cell counter.  Cells at 1 x 
106 confluency were resuspended in 1ml of cold 1X PBS.  Briefly, the cells were fixed in 
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absolute ethanol and stored at -20ºC.  The fixed cells were centrifuged at 1000 rpm, 
washed three times in cold 1X PBS and then resuspended in 1 ml of 50 µg/mL PI-
staining solution and 150 µl of 100 µg/ml of RNase A.  After incubation for 40 min at 
37ºC, cells were analyzed on FACSCalibur (Pozarowski & Darzynkiewicz, 2004).  
Statistical Analysis 
 The IC50 values for cytotoxicity assays were calculated using GraphPad prism 
software version 6.0.  For measuring differences between two groups, data were analyzed 
using two-tailed Unpaired Student t-tests with a p ≤ 0.05. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
		 30 
Results 
Cytotoxic Effect of Quercetin and Its Methylated Derivatives on MDA-MB 231 Cells 
 
 Cell viability was evaluated using classical trypan blue exclusion (TBE) assay.  
MDA-MB 231 triple negative breast cancer cells were treated with quercetin, 
isorhamnetin, tamarixetin, 3-O-methylquercetin, and pentamethyl quercetin at 
concentrations of 12.5, 25, 50, and 100 µM and harvested 72 h post-treatment (Figure 
2A).  The assay was repeated using HeLa cells (Figure 2B) to determine if the observed 
effects were specific to breast cancer cell, and on MCF-10A cells (Figure 2C), a non-
transformed breast cancer cell line, to determine if the cytotoxic effects of these 
compounds were specific to cancer cells.
 
A.	
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Figure 2.  Trypan blue exclusion assays performed on A) MDA-MB 231 cells, B) HeLa 
cells, and C) MCF -0A cells after treatment with 12.5, 25, 50, and 100 µM of quercetin 
and its methylated derivatives.  Percent viability was calculated in comparison to the 
negative DMSO control.  Error bars represent standard deviation.  The star indicates 
statistical significance, using p ≤ 0.05 in a student t-test, n=3. 
 
 
B.	
C.	
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The cells were prepared for the TBE assay as described in methods.  DMSO treated cells 
were used as a negative control.  The trypan blue dye is used to stain dead cells that do 
not have an intact membrane while live cells appear clear and are counted using an 
automated cell counter. The data were analyzed by calculating the IC50 curves for all 
treatments (Table 3).   
Table 3  
 IC50 calculation for cell death induced by quercetin and its methylated derivatives after 
72 h.  IC50 values are reported in µM.  Data in parenthesis indicate range for the 95% 
confidence interval.  
 
Compounds MDA-MB 231 MCF-10A HeLa 
Isorhamnetin 112.1 (75.24 to 167.10) 78.86 (34.85 to 178.40) 3.721 (3.116 to 4.44) 
Tamarixetin 16.72 (10.37 to 26.98) 35.46 (24.63 to 51.05) 5.453 (4.610 to 6.45) 
3-O-Methyl 
Quercetin 15.17 (13.07 to 17.61) 28.35 (20.27 to 39.64) 3.683 (1.313 to 10.33) 
Pentamethyl 
Quercetin 50.05 (38.99 to 64.25) 89.62 (61.70 to 130.20) 170.3 (92.53 to 313.50) 
Quercetin 175.9 (90.20 to 342.90) 90.42 (62.04 to 131.8) 9.983 (8.765 to 11.37) 
 
The IC50 data and the TBE assay data were used together to evaluate the 
cytotoxic abilities of the compounds.  The compounds 3-O-methylquercetin and 
tamarixetin were the most efficient in inducing cell death, but their effects were not 
specific to cancer cells.  Isorhamnetin was more effective in HeLa cells and MCF-10A 
cells but did not show the same efficacy in MDA-MB 231 cells.  Quercetin was also 
highly effective in HeLa cells, but not in the other two cell lines.  Pentamethyl quercetin 
was ineffective in all three cell lines.  In summary, our findings indicated that the 
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methylated derivatives of quercetin were more effective in inducing cell death than the 
parent quercetin molecule. 
Loss of Mitochondrial Outer Membrane Potential Induced by Quercetin and Its 
Methylated Derivatives 
 
 The MOMP of the three cell lines, MDA-MB 231, HeLa and MCF-10A cells, was 
measured after treatment with quercetin, isorhamnetin, tamarixetin, 3-O-methylquercetin, 
and pentamethyl quercetin at a concentration of 100 µM for 15 min and 24 h.  A 24 h 
washout experiment was also conducted in MDA-MB 231 cells.  The values of all 
compounds were compared to the positive control CCCP, a mitochondrial decoupler and 
the negative control (DMSO).  
A loss of MOMP was observed after 15 min incubation with all compounds 
except pentamethyl quercetin (Figure 3A). The red/green fluorescence ratios were higher 
after 24 h compared to the 15 min incubation.  No significant loss of MOMP was 
recorded in the 24 h washout experiment.  Similar results were observed with the HeLa 
cells (Figure 3B), which showed a significant loss of MOMP in all treatments except for 
pentamethyl quercetin.  The data from 15 min incubation with MCF-10A cells also show 
a significant loss of MOMP with all treatments (Figure 3C). 
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Figure 3.  Effect of Quercetin and its methylated derivatives on mitochondrial outer 
membrane potential (MOMP).  Flow cytometry data of A) MDA-MB 231 cells B) HeLa 
cells, and C) MCF-10A cells treated with 100 µM of quercetin and its methylated 
derivatives for 24 h/15 min and stained with JC-1 dye at 37oC.  Carbonyl cyanide  
3-cholorophenylhydrazone (CCCP) was used as positive control at a 50 µM 
concentration and DMSO was used as negative control.  The ratio of red to green 
fluorescence was calculated and compared to the control and plotted on a graph.  Error 
bars represent the standard deviation.  The star indicates statistical significance, using p ≤ 
0.05 in a student t-test, n=5. 
 
Measuring the Generation of Reactive Oxygen Species Upon Treatment with 
Quercetin and Its Methylated Derivatives  
 
 Generation of intracellular ROS is considered one of the significant moderators of 
apoptotic signaling in cancer treatment (Nicolini et al., 2013).  Thus, the redox status of 
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MDA-MB 231 cells on treatment with quercetin and its methylated derivatives was 
determined.  Cells were incubated with 100 µM quercetin, isorhamnetin, tamarixetin,  
3-O-methylquercetin, or pentamethyl quercetin along with the CM-H2DCFDA dye for 15 
min at 370C.  The chloromethyl derivative of H2DCFDA is an oxidation-sensitive 
fluorescent dye, which acts as an indicator of ROS in cells.  Tert-butyl hydroperoxide 
(TBHP) is a known inducer of ROS in cells and was used as a positive control.  The data 
were evaluated in comparison to the positive control (Figure 4A) to determine any 
increase in the level of ROS upon treatment with the compounds.  The compounds, along 
with TBHP, were also tested to determine their anti-oxidant potential.  
No significant difference was evident in the levels of intracellular ROS on 
treatment with quercetin or isorhamnetin (Figure 4B and 4C).  Previously a study 
demonstrated that the levels of ROS were not significantly different between quercetin 
treated cells and control cells, and our findings support these results (Chien et al., 2009).  
Upon individual THBP treatment of MDA-MB 231 cells with quercetin or isorhamnetin, 
a decrease in the levels of intracellular ROS was observed, further confirming the anti-
oxidant potential of these two compounds.  The levels of ROS measured upon treatment 
with tamarixetin and 3-O-methylquercetin (Figure 4D and 4E) were lower than the 
DMSO control indicating that no ROS was generated.   The combination of TBHP with 
tamarixetin and 3-O-methylquercetin decreased the levels of ROS produced by TBHP, 
but with a weaker anti-oxidant effect than seen with quercetin.  Pentamethyl quercetin 
(Figure 4F) did not show any significant change in the levels of ROS, nor did it decrease 
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the ROS generated by TBHP, suggesting a poor anti-oxidant activity, which is consistent 
with our cell viability data.  
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Figure 4. Flow cytometric analysis of the intracellular level of reactive oxygen species 
generated in MDA-MB 231 cells, displaying A) negative control DMSO and positive 
control TBHP and 100 µM of B) quercetin C) isorhamnetin D) tamarixetin  
E) 3-O-methyl quercetin, and F) pentamethyl quercetin.  The treated cells were stained 
using CM-H2DCFDA dye for 15 min at 37o C.  The legend to the right of the graph 
indicates the treatments.  All data were analyzed in comparison to the positive and 
negative control.  
 
 
E.	
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Induction of Cell Cycle Arrest 
 To assess whether the cell death induced by quercetin and its derivatives is 
mediated through alterations in cell cycle progression, the effect of these compounds on 
cell cycle phase distribution was evaluated using flow cytometry.  The data obtained from 
this experiment were then compared to our cell death data.  The MDA-MB 231 cells were 
treated with all compounds at a concentration of 100 µM and analyzed at 24 h and 48 h 
post treatment.  We used DMSO as a negative control, as it displays a normal distribution 
of the cell cycle. Cell cycle arrest was observed at G2/M phase, 24 h post treatment using 
quercetin, isorhamnetin, and tamarixetin and at S phase using pentamethyl quercetin 
(Figure 5A).  No significant change was evident in the cell cycle distribution with 3-O-
methyl quercetin. The results were not significantly changed by the 48 h treatment 
(Figure 5B).   
 
	
A
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Figure 5.  Cell cycle analysis of MDA-MB 231 cells after treatment with 100 µM of 
quercetin and its methylated derivatives.  The cells were harvested and fixed in 100% 
EtOH, then stained with PI and incubated with RNase A at 37o C.  The graphs represent 
data for A) 24 h treatment, and B) 48 h treatment.  Error bars represent standard 
deviation.  The star indicates statistical significance, using p ≤ 0.05 in a student t-test, 
n=3. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
B
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Discussion 
Quercetin and Its Methylated Derivatives Induce Dose-Dependent Dell death in 
MDA-MB 231 Cells  
 
We examined the effects of quercetin and its methylated derivatives 
(isorhamnetin, 3-O-methyl quercetin, or pentamethyl quercetin) on the survival of triple 
negative breast cancer MDA-MB 231 cells, HeLa cells, and MCF-10A cells.  
 Quercetin treatment weakly induced cytotoxicity in MDA-MB 231 cells, with an 
IC50 of 175 µM.  The data were consistent with a previous study which also showed 
quercetin as a weak inducer of cell death in the MDA-MB 231 cell line (Yadegarynia et 
al., 2012). Quercetin was more cytotoxic in HeLa cells, which suggests that the 
mechanism through which quercetin induces cell death may be different for various types 
of cancer cells.  Quercetin has previously been shown to actively induce cell death in 
human cervical cancer, HeLa cells, through mitochondrial-mediated apoptosis and cell 
cycle arrest, which is carried out by p53 induction and NF-κB inhibition (Vidya 
Priyadarsini et al., 2010).  Our data support this study.  The difference in the mechanism 
of cell death in the MDA-MB 231 cells and HeLa cells could be because of the p53 
mutation in the triple negative breast cancer MDA-MB 231 cell line, as the absence of 
this transcription factor results in an alternate pathway of cell death.  We recorded no 
decrease in cell viability in MCF 10A cells on treatment with lower concentrations of 
quercetin, in contrast to the significant changes seen at the higher dose of 100 µM.  The 
MCF-10A cell line is an immortalized, non-transformed, normal breast epithelial cell 
line.  Our findings indicated that the cytotoxic effect of quercetin might be selective to 
tumor cells; however, more research needs to be done to determine the precise 
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mechanism.  Isorhamnetin moderately induced cytotoxicity in MDA-MB 231 cells with 
an IC50 of 112.1 µM.  Results from a previous study of isorhamnetin showed a similar 
cytotoxic potential in human colon carcinoma HCT-116 cells, with an IC50 OF 72 µM 
after 48 h of treatment (Jaramillo et al., 2010).  We found that isorhamnetin decreased 
cell viability in MCF-10A cells at concentrations of 100 µM and 50 µM.  Tamarixetin 
and 3-O-methyl quercetin were significant in their cytotoxic potential in all three cell 
lines.  Both compounds were found to be potent inducers of cell death, although their 
cytotoxicity was much higher in HeLa cells as compared to the other cell lines.  
Pentamethyl quercetin showed weak induction of cytotoxicity in all three cell lines, 
which is unsurprising as it was previously shown to be a weak inducer of cell death in 
MDA-MB 231 (Yadegarynia et al., 2012).  
We speculate that the five hydroxyl groups on the quercetin molecule are 
responsible for its ability to induce cell death, although methyl capping of one or more of 
these free hydroxyl groups may improve compound cytotoxicity.  Pentamethyl quercetin 
has methylation on all five hydroxyl groups, which may explain why we found it to 
induce cell death weakly.  If this is the case, it may also suggest that to be able to cause 
significant cell death, it is necessary that quercetin compounds have at least one free 
hydroxyl group.  Using our findings, we can arrange quercetin compounds in the order of 
their cytotoxic potential based on the number of free hydroxyl groups, with 3-O-
methylquercetin and tamarixetin being more strongly cytotoxic and isorhamnetin, 
quercetin, and pentamethyl quercetin being weakly cytotoxic. 
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The Induction of Cell Death is Through the Mitochondria-Mediated Pathway of 
Apoptosis 
 
The loss of mitochondrial outer membrane potential (MOMP) is an indicator of 
the induction of apoptosis.  The intrinsic pathway of apoptosis occurs due to the release 
of cytochrome c from the mitochondria.  We measured the loss of MOMP to determine if 
quercetin and its methylated derivatives induce apoptosis through the intrinsic pathway 
mediated via the mitochondria.  Our data for the 15 min treatment show that all 
compounds caused a significant loss of MOMP, suggesting that quercetin, isorhamnetin, 
tamarixetin, and 3-O-methyl quercetin induce cell death through the mitochondrial 
pathway of apoptosis.  Pentamethyl quercetin did not show any significant loss of MOMP 
in MDA-MB 231 cells and HeLa cells.  These data were consistent with the cell death 
data in supporting the weak cytotoxic effects of pentamethyl quercetin, further 
highlighting the importance of the free hydroxyl groups in cell death.  
We also conducted the experiment as a 24 h treatment, washing the cells with 
PBS after trypsinization prior to analysis.  With this treatment duration, the loss of 
MOMP was significantly less compared to the 15 min treatment in which the cells were 
not washed.  Our data suggest that the effects induced by these compounds are somehow 
reversed on washing the cells with PBS.  The exact mechanism behind this is not clear 
and more studies should be conducted.  A previous study has shown significant loss of 
MOMP in human glioblastoma U373MG cells when treated with 75 µM and 100 µM of 
quercetin for 48 h. These cells were also trypsinized and washed prior to analysis (Kim et 
al., 2013).  Our data were not consistent with these findings.  However, from the loss of 
MOMP we observed in HeLa cells, we can determine that the effect of these compounds 
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is not cell line dependent.  The data obtained from analyzing MCF-10A cells highlight 
that the cytotoxicity induced by these compounds may not be specific to tumor cells.  
Studies are currently being conducted to create targeting strategies for these compounds, 
which will allow us to more specifically deliver treatments and prevent the killing of 
healthy cells. 
Quercetin and Its Methylated Derivatives Act as an Anti-Oxidant Not a Pro-oxidant 
 
Recent studies have revealed that quercetin may behave as both as anti-oxidant 
and pro-oxidant based on the intracellular concentration and free radical source 
(Metodiewa et al., 1999).  We tested quercetin and its methylated derivatives on triple 
negative breast cancer cell line MDA-MB 231 to determine if these flavonol compounds 
generated reactive oxygen species intracellularly.  Based on our findings, we did not see 
any change in the level of reactive oxygen species (ROS) upon treatment with the 
flavonol compounds when compared to our positive control TBHP and negative control 
DMSO treatments.  Our data demonstrate that quercetin, isorhamnetin, 3-O-methyl 
quercetin, and pentamethyl quercetin do not generate ROS in MDA-MB 231 cells when 
treated with a concentration of 100 µM for 15 min at 37oC.  We speculate that the 
compounds mentioned above do not exhibit pro-oxidant activity in the MDA-MB 231 
cell line and that the pathway through which these compounds induce cell death is not by 
generation of ROS.  Data from a previous study conducted in leukemia cells have shown 
tamarixetin to cause a fourfold increase in levels of ROS as compared to the control 
(Nicolini et al., 2013).  While the data were contradictory to our results, they may suggest 
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that the mechanism through which tamarixetin induces cell death varies with different 
types of cancer.  
On treating the cell with both TBHP and the flavonol compounds, a decrease in 
the levels of ROS was evident, indicating the anti-oxidant potential of these compounds.  
This potential was different for each compound tested, the highest resulting from 
treatment with quercetin and 3-O-methyl quercetin, followed by treatment with 
tamarixetin and isorhamnetin.  There was no decrease in levels of ROS upon treatment 
with pentamethyl quercetin.  
Alterations in Cell Cycle Distribution May Occur Prior to Cell Death After 
Treatment with Quercetin and Its Methylated Derivatives  
 
 Literature has shown that quercetin-induced cell death may be attributed to 
apoptosis mediated by cell cycle arrest.  Previous studies have reported a significant 
arrest with quercetin at the G2/M phase of the cell cycle, with a promotion of S-phase of 
the cell cycle (Chien et al., 2009).  G2/M arrest of cell cycle progression was also 
demonstrated following quercetin treatment in human leukemia U937 cells (Chou et al., 
2010).  Arrest at the G2/M phase of cell cycle was also evident consistently across 
treatment with quercetin derivatives, except for pentamethyl quercetin, which shows cell 
cycle arrest at the G1 phase.  The G1 phase arrest by pentamethyl quercetin has been 
previously observed in MDA-MB 231 cell lines  (Yadegarynia et al., 2012).  Our study 
indicates that although these compounds alter the cell cycle progression, this alteration 
may not be associated with the observed induction of cell death.  More studies should be 
conducted to investigate the role of cell cycle alterations in flavonol induced cell death.  
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 Taken together, we have determined that the structure of the quercetin parent 
molecule likely plays a significant role in its cytotoxic potential.  The increase in cell 
death seen upon treatment with tamarixetin and 3-O-methyl quercetin suggests that 
methyl capping of the free hydroxyl groups at position 3, and position 4’ of the quercetin 
molecule improves the cytotoxic potential of the compound.  However, this also 
compromises the anti-oxidant activity exhibited by quercetin.  In this case, quercetin 
derivatives with fewer free hydroxyl groups will demonstrate poorer antioxidant activity 
than derivatives with greater hydroxyl group availability.  The methyl capping on 
position 3’ of quercetin appears to moderately affect its ability to induce cell death, 
suggesting that the hydroxyl group at the 3’ position may not be as reactive as the one on 
3 and 4’.  With all five hydroxyl groups methylated, pentamethyl quercetin was found to 
induce the least cytotoxicity, which is consistent with the theory that at least one free 
hydroxyl group must be present for quercetin to be able to induce cell death.  
Furthermore, methyl-capping of all five hydroxyl groups may render the quercetin 
molecule unreactive.   
 We also conclude that these compounds induce cell death through the 
mitochondrial-mediated pathway of apoptosis.  The flavonol compounds studied do not 
act as pro-oxidants when they induce cell death, but rather, they exhibit a radical 
scavenging property.  Cell death may be accompanied by alterations in the cell cycle 
progression, but lacks validity as an indicator to determine the mechanism of apoptosis.  
Further studies need to be carried out to clearly understand how the structure of the 
quercetin molecule affects its cytotoxicity.  To identify the most reactive free hydroxyl 
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groups, comparative analysis of additional methylated derivatives with variations in the 
methyl capping positions must be conducted.  To underline the exact mechanism of cell 
death, we need to measure the levels of Bax and Bak and levels of cytochrome c in the 
cytosol, all of which collectively serve to indicate intrinsic apoptosis.  
 In conclusion, additional experiments will help us to better understand the 
properties of these flavonol compounds in cancer and explore their role as potential 
chemotherapeutic agents.  This knowledge will allow us as researchers to modulate these 
derivatives and exploit their properties to serve as natural chemo-toxic agents in the 
treatment of cancer.  
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